No Data
CGN Nuclear Technology Development Chair Resigns
CGN Nuclear Technology Development (000881.SZ): Chairman and Director Li Yong resigns.
On February 12, Glodon announced that CGN Nuclear Technology Development (000881.SZ) received a written resignation letter from Mr. Li Yong, Chairman of the Board of Directors, on February 12, 2025. Mr. Li Yong has requested to resign from his positions as Chairman, Director and Head of the Board of Directors Global Strategy Committee due to work adjustments, and will no longer hold any position in the company after his resignation.
CGN Nuclear Technology Development (000881.SZ): Currently, the equipment cannot be applied to Transgenic breeding.
On January 24, Gelonghui reported that CGN Nuclear Technology Development (000881.SZ) stated on the investor interaction platform that the current construction of the electronic accelerator breeding platform mainly utilizes radiation-induced mutation breeding technology to create new germplasm resources for crops and cultivate new varieties, without involving the Transgenic breeding field! Currently, the equipment cannot be applied to Transgenic breeding!
CGN Technology: 2024 Annual Performance Forecast
CGN Nuclear Technology Development (000881.SZ): A forecasted loss of 0.29 billion yuan to 0.42 billion yuan for the 2024 fiscal year.
On January 17, Gelonghui reported that CGN Nuclear Technology Development (000881.SZ) announced the performance forecast for 2024, expecting a Net income loss of 0.29 billion yuan to 0.42 billion yuan attributable to the shareholders of the listed company, compared to a loss of 0.737 billion yuan in the same period last year; the Net income loss after excluding non-recurring gains and losses is expected to be between 0.45 billion yuan and 0.64 billion yuan, versus a loss of 0.961 billion yuan in the same period last year; the basic EPS loss is estimated to be between 0.3067 yuan/share and 0.4442 yuan/share. Compared to 2023, the company's losses are expected to decrease in 2024, but due to the following factors, the anticipated Net income for 2024 is negative, mainly
CGN Nuclear Technology Development (000881.SZ): Juner Company currently uses PEEK Resin for blending and producing modified PEEK products.
On December 31, Glonghui reported that CGN Nuclear Technology Development (000881.SZ) stated on its investor interaction platform that the company currently does not manufacture PEEK. Its subsidiary, Juner Company, is currently using PEEK Resin for blending to produce modified PEEK products, which are mainly used in high-end electronic and electrical components, with currently low sales volume.
CGN Nuclear Technology Development Co., Ltd. (SZSE:000881) Surges 25% Yet Its Low P/S Is No Reason For Excitement
